港股市场策略周报 2026.02.23-2026.03.01 | 分析师： | 刘景锋 | | --- | --- | | 中央编号： | BXJ117 | | 联系电话： | 852-6222 4563 | | 邮箱： | liujingfeng@cnzsqh.hk | 1 港股市场策略周报 - 投资要点 3 l 港股市场表现回顾 l 港股市场估值水平 l 港股市场回购统计 l 港股市场宏观环境跟踪与展望 l 港股市场表现回顾： n 本周港股整体表现稳健，市场呈现结构性分化，能源等板块领涨，而科技股承压。本周恒生综指/恒生指数/恒生科技分 别+0.42%/+0.82%/-1.41%。本周市场一级行业板块中9个行业上涨、3个行业下跌，医疗保健业、非必需性消费、 资讯科技业分别下跌4.95%、1.82%、0.98%。本周整体情况为：大盘股、成长股、价值股表现占优。 n 截至本周末，恒生综指的5年PE（TTM）估值分位点为88.09%，估值水平接近5年均值向上一个标准差。 l 港股市场宏观环境： 2 n 基本面：春节假期居民出行热度再创新高，地产销售同比转正；政治局召开会议，强调要实施更加积极有为的宏观政策。 n ...

Group 1 - Aihua Long faces regulatory scrutiny after being warned about its involvement in the brain-machine interface sector, leading to a formal investigation and losses in both its main business and stock trading activities [1] - Rongbai Technology's order value plummeted from 120 billion to a fine of 9.5 million due to false disclosures, with Chairman Bai Houshan fined 3 million [1] - BYD aims to sell 1.3 million vehicles overseas by 2026, contributing to China's export of over 7 million vehicles, marking a third consecutive year of global leadership in this sector [1] Group 2 - Haichang Intelligent has accounts receivable of 450 million, accounting for 56% of its revenue, and is involved in a patent lawsuit that may result in a compensation of 10.83 million [1] - Zhiji Motors has set a target of selling 81,000 vehicles by 2025 but has failed to meet its targets for three consecutive years, with CEO Liu Tao apologizing for safety concerns related to Tesla [1] - China Shenhua's restructuring plan, involving the acquisition of 12 companies, was approved in just six days, with a total value of 133.6 billion [1] Group 3 - Changchun High-tech anticipates a loss of 1 billion in the fourth quarter due to product price adjustments, while investing over 2 billion annually in R&D to reduce reliance on growth hormones [1] - Vanke's losses are expected to deepen, projecting a loss of 82 billion by 2025, with a bond extension of 6.8 billion and additional support of 2.36 billion from Shentie [1] - GAC Group has issued a rare profit warning, expecting losses between 8 billion to 9 billion, with CEO Feng Xingya reiterating the focus on three major battles for a turnaround [1] Group 4 - Nanhai Rural Commercial Bank was fined 3.8 million, with its net interest margin dropping to 1.15% after eight years of unsuccessful A-share market attempts [1] - Yuanji Food is closing one out of every three new stores, with Yuan Lianghong's wife holding shares in six supplier companies involved in related transactions worth 130 million [1] - "Cheese Queen" Chai Xiu has exited the market after costly marketing efforts, leading to a 70% drop in the stock price of Miaokelan Duo, with Mengniu taking full control [1] Group 5 - Zijin Mining has invested an additional 28 billion in overseas acquisitions, projecting a profit of 51 billion by 2025, with its market value stabilizing above 1 trillion [1] - Hunan Gold's restructuring of 2.7 billion in assets aims to increase resource reserves, benefiting from rising prices of antimony and tungsten, resulting in record profits exceeding 1.27 billion [1] - A shareholder named Yu Han was penalized over 1 billion for manipulating stock prices, while Doctor's Optical spent 50 million on traffic acquisition but only 3 million on R&D [1] Group 6 - SAIC-GM-Wuling's debt ratio has risen to 85.24%, despite a 20.5% increase in sales, which remains 53.5 thousand units below its peak [1]

Group 1 - The Ministry of Commerce reported progress in consultations regarding the EU-China electric vehicle case, emphasizing the need for common guidance on price commitments for Chinese exporters of pure electric vehicles to the EU, which reflects the spirit of dialogue and negotiation between China and the EU [2] - The Chinese government is strengthening export controls on dual-use items to Japan to safeguard national security and fulfill international obligations, while maintaining a stable global supply chain for critical minerals [3] - The National Development and Reform Commission, along with other ministries, released guidelines for government investment funds, focusing on strategic areas and encouraging investment in emerging industries and technological innovation [4] Group 2 - Shanghai Gold Exchange noted significant fluctuations in precious metal prices due to multiple factors, urging members to monitor market changes and maintain risk management plans [4] - Companies like ZhiTe New Materials and Xiangwei New Materials are taking measures to address stock trading volatility, including suspending trading for verification [7][8] - Companies such as ZhiTe New Materials and Galaxy Electronics are facing scrutiny due to significant stock price movements, with potential risks of irrational speculation [13][18] Group 3 - Companies like Chaohongji and Yatai Co. are projecting substantial net profit growth for 2025, with estimates of 125%-175% and 120%-170% year-on-year increases, respectively [22][23] - WuXi AppTec anticipates a net profit growth of approximately 102.65% for 2025, indicating strong performance expectations [24]

Core Insights - As of January 13, 2026, 140 companies in the A-share market have released performance forecasts for 2025, with 94 providing specific net profit ranges [1] - Among these, 72 companies are expected to achieve net profits exceeding 100 million yuan, and 22 companies are projected to have net profits over 1 billion yuan [1] Group 1: Companies with High Net Profits - Zijin Mining, WuXi AppTec, Luxshare Precision, and Shanghai Port Group are expected to have net profits exceeding 10 billion yuan, with projected profits of 51.5 billion yuan, 19.151 billion yuan, 16.852 billion yuan, and 13.4 billion yuan respectively [2] - The total market capitalization of Zijin Mining is 979.21 billion yuan, while WuXi AppTec has a market cap of 294.94 billion yuan [2] Group 2: Companies with Doubling Net Profit Growth - 19 companies are expected to double their net profits compared to the previous year, with notable growth rates including Zhongke Lanyun at 371.51%, Chuanhua Zhili at 308.82%, and Bai'ao Saitou at 303.57% [1][3] - Tian Ci Materials, China Shipbuilding Defense, and Guangku Technology also show significant growth rates exceeding 150% [1][3]

Group 1 - On January 6, a total of 6 stocks received buy ratings from brokerages, with 1 stock announcing a target price [1] - BYD ranked highest in target price increase potential, with a projected rise of 40.01% [1] - The sectors with the most stocks receiving buy ratings include pharmaceuticals, biotechnology and life sciences, medical equipment and services, and capital goods, each with 1 stock [1]

Group 1 - A total of 12 stocks received buy ratings from brokerages on December 12, with one stock announcing a target price [1] - The stock with the highest target price, Hars, has a projected increase of 25.93% [1] - Among the rated stocks, 9 maintained their ratings while 3 received ratings for the first time [1] Group 2 - The sectors with the most stocks receiving buy ratings include Food, Beverage & Tobacco (3 stocks), Pharmaceuticals (2 stocks), and Biotechnology & Life Sciences and Materials II (1 stock each) [1]

Core Insights - The implementation of ESG principles has become a global trend, particularly accelerated in China under the dual carbon goals and high-quality development strategies, making ESG a mandatory aspect for companies in the pharmaceutical, biotechnology, and life sciences sectors [1] Group 1: ESG Reporting and Performance - As of May 5, 2025, 161 companies in the A-share pharmaceutical, biotechnology, and life sciences sector have actively disclosed their 2024 ESG reports, compared to 134 companies for 2023 [2] - The UCCR ESG team conducted a comprehensive analysis of the E (Environmental) performance of these companies for 2023 and 2024, using their ESG rating model and standards [2] Group 2: Environmental Management Goals - In 2024, 67.08% of companies established clear environmental management goals, a significant increase from 41.04% in 2023, marking a rise of 26.04% [3] - In 2024, 32.30% of companies had somewhat clear environmental management goals needing further refinement, down from 58.96% in 2023, a decrease of 26.66% [3] Group 3: Energy Conservation and Renewable Resources - In 2024, 93.79% of companies formulated policies on energy conservation and renewable resources, compared to 100% in 2023 [6] - The percentage of companies with comprehensive policies to effectively promote ESG construction decreased slightly from 48.51% in 2023 to 47.20% in 2024 [6] Group 4: Environmental Information Disclosure - In 2024, 59.01% of companies established dedicated departments for environmental information disclosure, an increase from 47.76% in 2023 [8] - The proportion of companies with complete and high-quality environmental information disclosure rose from 16.42% in 2023 to 35.40% in 2024 [10] Group 5: Resource Recycling and Waste Management - In 2024, 6.83% of companies had high levels of resource recycling, down from 20.15% in 2023, indicating a decline of 13.32% [12] - The percentage of companies with environmentally friendly waste disposal methods decreased from 23.13% in 2023 to 10.56% in 2024, a drop of 12.57% [14]

Group 1 - The core viewpoint of the news is that the Nasdaq IPO market is experiencing a significant resurgence, with 277 IPOs completed in 2025 and total fundraising exceeding $50 billion, indicating strong confidence in global capital markets [2] - The IPO market's recovery is supported by multiple factors, including a record high in corporate earnings surprises and a gradual recovery in small-cap company profits, which have laid a solid foundation for the IPO market [5] - The "IPO Pulses" index, a key indicator of IPO activity, has risen for five consecutive months, reaching its highest point in eight months, signaling a sustained increase in IPO activities [5] Group 2 - In 2026, Nasdaq will launch a new dual listing exchange in Texas, allowing companies to retain their original listing status while also listing in Texas, which recognizes Texas's economic strength and innovation ecosystem [8] - This new platform aims to attract emerging tech companies relocating from Silicon Valley to Texas, providing localized capital support and challenging New York's traditional financial center status [10] - The AI and biotech sectors are becoming increasingly attractive for IPOs, driven by policy support and technological advancements, with significant interest from Chinese companies in these fields [11][13] Group 3 - The commercialization of AI is accelerating, with a surge in demand for efficiency tools and vertical industry applications, leading to a wave of IPOs in this sector [12] - The biotech and life sciences sectors are also thriving, with a high willingness among Chinese biotech companies to list in the U.S., reflecting strong growth potential and technological barriers [13] - Companies looking to enter the Nasdaq IPO market must prepare by focusing on high-growth sectors, establishing compliance frameworks, and partnering with professional service providers to navigate the listing process effectively [14]

Investment Rating - The report maintains an "Outperform" rating for the Hong Kong stock market [4] Core Insights - The Hong Kong stock market has shown a balanced increase across all styles, with the innovative drug sector leading the gains [1] - The Hang Seng Index increased by 1.3%, with the Hang Seng Composite Index also rising by 1.3% [1] - The report highlights a significant divergence in performance among major concept indices, with the Hang Seng Biotechnology Index rising by 7.0% and the Hang Seng Internet Index declining by 2.0% [1] Summary by Sections Market Performance - The Hang Seng Index's valuation increased by 1.1% to 12.2x, while the Hang Seng Composite Index's valuation rose by 1.3% to 12.1x [2] - The report notes that 20 industries saw an increase in valuation, with notable rises in Steel (+14.0%), Agriculture (+7.4%), Real Estate (+6.8%), and Pharmaceuticals (+6.2%) [2] Earnings Expectations - The earnings per share (EPS) for the Hang Seng Index increased by 0.4% compared to the previous week [3] - The report indicates that 18 industries experienced upward revisions in EPS, with the most significant increases in Electric Power Equipment and New Energy (+4.3%) and Construction (+1.8%) [3]

Group 1 - Public funds have significantly increased their allocation to Hong Kong stocks, with the investment market value reaching 1.362211 trillion yuan by the end of Q3 2025, a 43.09% increase from 951.985 billion yuan at the end of Q2 2025 [1] - The market value of equity and index funds in Hong Kong stocks reached 1.231653 trillion yuan and 701.284 billion yuan, reflecting increases of 45.02% and 73.07% respectively [1] - The surge in public fund holdings in Hong Kong stocks indicates a structural transformation in asset allocation, driven by the attractiveness of technology and value stocks [1] Group 2 - The influx of funds into Hong Kong ETFs is attributed to three main reasons: valuation advantages compared to A-shares, the convenience and low cost of ETF trading, and risk diversification benefits [2] - The top Hong Kong stocks that public funds increased their holdings in include SenseTime-W, Alibaba Health, China Biologic Products, and others, primarily in the information technology and healthcare sectors [2] - A total of 38 cross-border ETFs attracted a net inflow of 49.561 billion yuan in Q3, with a year-to-date net inflow of 72.642 billion yuan as of November 12 [2]